Molecular Solutions (RMD)

Roche Molecular Diagnostics develops and produces innovative tests based on the Nobel Prize-winning discovery of the polymerase chain reaction (PCR). The tests developed by this business area for oncology, virology, HPV, microbiology and for screening blood products are used around the world by researchers, doctors, patients, hospitals, laboratories and blood banks.

A new generation of RMD tests supports healthcare providers in choosing medications based on molecular characteristics of diseases and in monitoring treatments. The systems developed by RMD for screening blood and blood products help ensure that these products are safe before they come into contact with patients.